# OnCo record lymphoma-b-versus-t-cell (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/lymphoma-b-versus-t-cell/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "lymphoma-b-versus-t-cell" ;
  schema:name "B-cell, T-cell and NK-cell lymphoma"@en ;
  schema:alternateName "B-cell lymphoma"@en, "T-cell lymphoma"@en, "NK-cell lymphoma"@en, "cell of origin"@en, "lineage"@en ;
  schema:description "The first thing a lymphoma report says is which kind of lymphocyte the cancer came from. B cells make antibodies and carry a surface protein called CD20; T and NK cells kill infected cells directly and carry no CD20. That single difference is why B-cell lymphomas have had thirty years of new antibody treatments and T-cell lymphomas have not."@en ;
  schema:url <https://onco.cc/terms/lymphoma-b-versus-t-cell/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1038/bjc.2015.94> ;
  onco:tag "heme", "lymphoma" ;
  onco:related <https://onco.cc/terms/lymphoma-type/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/targets/cd20/> ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/brentuximab-vedotin/> .